Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective
Abstract Multiple myeloma (MM) is a prevalent hematological malignancy. Resource-constrained settings such as the Middle East are particularly burdened by the increasing trends in MM morbidity and mortality in addition to challenges in the management of MM. It thus becomes necessary to identify and...
Main Authors: | Ahmad Ibrahim, Nabil Chamseddine, Jean El-cheikh, Colette Hanna, Walid Moukadem, Fady Nasr, Ahmad Younis, Ali Bazarbachi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAABRON PRESS
2022-08-01
|
Series: | Clinical Hematology International |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44228-022-00017-3 |
Similar Items
-
Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium
by: Agnieszka Krzywdzińska, et al.
Published: (2021-10-01) -
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma
by: Noemí Puig, et al.
Published: (2021-09-01) -
Steps towards a Multiple Myeloma Cure?
by: Alessandro Gozzetti, et al.
Published: (2022-09-01) -
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New
by: Carlos Bravo-Pérez, et al.
Published: (2021-08-01) -
Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma
by: Jing Wang, et al.
Published: (2024-02-01)